REVVITY, INC. — Director's Dealing 2021

Aug 31, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PERKINELMER INC (PKI)
CIK: 0000031791
Period of Report: 2021-08-30

Reporting Person: Okun Andrew (Please See Remarks)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-30	Common Stock	M	3054	$81.29	Acquired	11306	Direct
2021-08-30	Common Stock	S	200	$184.16	Disposed	11106	Direct
2021-08-30	Common Stock	S	126	$185.24	Disposed	10980	Direct
2021-08-30	Common Stock	S	800	$186.72	Disposed	10180	Direct
2021-08-30	Common Stock	S	1328	$188.02	Disposed	8852	Direct
2021-08-30	Common Stock	S	600	$188.85	Disposed	8252	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-08-30	NQ Stock Option (right to buy)	$81.29	M	3054	Disposed	2025-01-30	Common Stock (3054)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	8	Indirect

Footnotes

F1: The Exercise Price included on the Form 4 filed on February 1, 2018 for the Reporting Person was incorrectly reported due to administrative error.

F2: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by Mr. Okun on July 29, 2021.

F3: The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $184.05 to $184.27. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.

F4: The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $185.11 to $185.27. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.

F5: The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $186.32 to $187.15. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.

F6: The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $187.36 to $188.24. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.

F7: The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $188.44 to $189.26. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.

F8: This option became exercisable in three equal annual installments beginning on January 30, 2019, which was the first anniversary of the date on which the option was granted.